Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit Faucher

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Infection|June 11, 2011
Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical casesBenoit Faucher, Christelle Pomares, Sabrina Fourcade, et al.
Clinical Immunology (Orlando, Fla.)|February 8, 2022
Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eyeCamille Mettler, Cassandre Petit, Vincent Ernest, et al.
Clinical Rheumatology|September 21, 2020
Acute severe hepatitis in adult-onset Still's disease: case report and comprehensive review of a life-threatening manifestationRomain Muller, Antoine Briantais, Benoit Faucher, et al.
European Journal of Internal Medicine|March 9, 2010
Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III sclerodermaBenoit Faucher, Philippe Stein, Brigitte Granel, et al.
Eclinicalmedicine|June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
Journal of Neurology|February 1, 2025
Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Blood|July 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndromePaul Breillat, Francesco Carbone, Emilie Lereclus, et al.
Blood|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX groupVincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
Annals of the Rheumatic Diseases|May 22, 2024
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEXJerome Hadjadj, Yann Nguyen, Dalila Mouloudj, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Infection|June 11, 2011
Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical casesBenoit Faucher, Christelle Pomares, Sabrina Fourcade, et al.
Clinical Immunology (Orlando, Fla.)|February 8, 2022
Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eyeCamille Mettler, Cassandre Petit, Vincent Ernest, et al.
Clinical Rheumatology|September 21, 2020
Acute severe hepatitis in adult-onset Still's disease: case report and comprehensive review of a life-threatening manifestationRomain Muller, Antoine Briantais, Benoit Faucher, et al.
European Journal of Internal Medicine|March 9, 2010
Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III sclerodermaBenoit Faucher, Philippe Stein, Brigitte Granel, et al.
Eclinicalmedicine|June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
Journal of Neurology|February 1, 2025
Neurological manifestations in patients with VEXAS syndromeCharlotte Bert-Marcaz, Étienne Fortanier, Antoine Briantais, et al.
Blood|July 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndromePaul Breillat, Francesco Carbone, Emilie Lereclus, et al.
Blood|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from the FRENVEX groupVincent Jachiet, Olivier Kosmider, Maxime Beydon, et al.
Annals of the Rheumatic Diseases|May 22, 2024
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEXJerome Hadjadj, Yann Nguyen, Dalila Mouloudj, et al.
Pageof 2